Abstract
Zinc is a micronutrient that plays an integral part in the normal functioning of the human body. Recent studies have elucidated the intricate physiology of zinc homeostasis. It has been shown to have immunomodulatory, anti-oxidant and anti-inflammatory roles. However, the application of this new understanding of zinc homeostasis to chronic inflammatory, infectious and auto-immune dermatological conditions is lacking. Evidence based support to the value of using oral zinc supplementation in various diseases is limited. Literature searches showed a paucity of prospective randomized controlled trials. Most literature on the use of zinc in dermatological conditions is largely anecdotal, based on small case series, or individual case reports. Diseases clearly linked to defective zinc absorption or nutritional deficiencies such as acrodermatitis enteropathica and other acquired zinc deficiency states respond rapidly to oral zinc supplementation. As a consequence, oral zinc supplementation remains a first line agent for these conditions. On the other hand, for most other conditions linked to mild to moderate deficiencies of zinc, its use remains limited as a second line agent or as a last measure in certain patients in whom conventional treatment has failed. Further research and adequate double blinded randomized control trials are needed in future. These should evaluate the efficacy of treatment with oral zinc in patients as compared to conventional treatments and would help to reveal the clinical value of using zinc supplementation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- AE:
-
Acrodermatitis enteropathica
- ALP:
-
Alkaline phosphatase
- BD:
-
Behçets disease
- DNA:
-
Deoxyribonucleic acid
- DRI:
-
Dietary reference intake
- ENL:
-
Erythema nodosum leprosum
- IFN:
-
Interferon
- IL:
-
Interleukin
- MTF-1:
-
Metal response element factor 1
- NAE:
-
Necrolytic acral erythema
- OCMI:
-
Oral clinical manifestation index
- RDA:
-
Recommended daily allowance
- RNA:
-
Ribonucleic acid
- SLC:
-
Solute linked carrier
- ZIP:
-
Zrt-Irt-like protein
- ZnT:
-
Zinc transporter
References
Abeck, D., Korting, H.C. and Braun-Falco, O., 1992. Folliculitis decalvans. Long-lasting response to combined therapy with fusidic acid and zinc. Acta Dermato-Venereologica 72, 143–145.
Al-Gurairi, F.T., Al-Waiz, M. and Sharquie, K.E., 2002. Oral zinc sulphate in the treatment of recalcitrant viral warts: randomized placebo-controlled clinical trial. British Journal of Dermatology 146, 423–431.
Arroyo, J.F. and Cohen, M.L., 1993. Improvement of yellow nail syndrome with oral zinc supplementation. Clinical and Experimental Dermatology 18, 62–64.
Bae, Y.S., Hill, N.D., Bibi, Y., Dreiher, J. and Cohen, A.D., 2010. Innovative uses for zinc in dermatology. Dermatologic Clinics 28, 587–597.
Barnes, P.M. and Moynahan, E.J., 1973. Zinc deficiency in acrodermatitis enteropathica: multiple dietary intolerance treated with synthetic diet. Proceedings of the Royal Society of Medicine 66, 327–329.
Bolotin, D., Racz, M.I., Petronic-Rosic, V. and Sethi, A., 2010. Acquired combined nutritional deficiency presenting as psoriasiform dermatitis. Journal of the American Academic of Dermatology 62, 715–718.
Brocard, A., Knol, A.C., Khammari, A. and Dreno, B., 2007. Hidradenitis suppurativa and zinc: a new therapeutic approach. A pilot study. Dermatology 214, 325–327.
Dreno, B., Amblard, P., Agache, P., Sirot, S. and Litoux, P., 1989. Low doses of zinc gluconate for inflammatory acne. Acta Dermato-Venereologica 69, 541–543.
Dreno, B., Moyse, D., Alirezai, M., Amblard, P., Auffret, N., Beylot, C., Bodokh, I., Chivot, M., Daniel, F., Humbert, P., Meynadier, J. and Poli, F., 2001. Multicenter randomized comparative double-blind controlled clinical trial of the safety and efficacy of zinc gluconate versus minocycline hydrochloride in the treatment of inflammatory acne vulgaris. Dermatology 203, 135–140.
El Darouti, M. and Abu el Ela, M., 1996. Necrolytic acral erythema: a cutaneous marker of viral hepatitis C. International Journal of Dermatology 35, 252–256.
Goransson, K., Liden, S. and Odsell, L., 1978. Oral zinc in acne vulgaris: a clinical and methodological study. Acta Dermato-Venereologica 58, 443–448.
Hanas, J.S., Hazuda, D.J., Bogenhagen, D.F., Wu, F.J.-H. and Wu, C.-W., 1983. Xenopus transcription factor A requires zinc for binding to the 5 S RNA gene. Journal of Biological Chemistry 258, 14120–14125.
Hillstrom, L., Pettersson, L., Hellbe, L., Kjellin, A., Leczinsky, C.G. and Nordwall, C., 1977. Comparison of oral treatment with zinc sulphate and placebo in acne vulgaris. British Journal of Dermatology 97, 681–684.
Hoque, S.R., Mansour, S. and Mortimer, P.S., 2007. Yellow nail syndrome: not a genetic disorder? Eleven new cases and a review of the literature. British Journal of Dermatology 156, 1230–1234.
Isard, O., Knol, A.C., Aries, M.F., Nguyen, J.M., Khammari, A., Castex-Rizzi, N. and Dreno, B., 2010. Propionibacterium acnes Activates the IGF-1/IGF-1R System in the Epidermis and Induces Keratinocyte Proliferation. Journal of Investigative Dermatology 131, 59–66.
James, K.A., Burkhart, C.N. and Morrell, D.S., 2009. Emerging drugs for acne. Expert Opinions on Emerging Drugs 14, 649–659.
Kay, R.G., Tasman-Jones, C., Pybus, J., Whiting, R. and Black, H., 1976. A syndrome of acute zinc deficiency during total parenteral alimentation in man. Annals of Surgery 183, 331–340.
Lansdown, A.B., Mirastschijski, U., Stubbs, N., Scanlon, E. and Agren, M.S., 2007. Zinc in wound healing: theoretical, experimental, and clinical aspects. Wound Repair and Regeneration 15, 2–16.
Liden, S., Goransson, K. and Odsell, L., 1980. Clinical evaluation in acne. Acta Dermato-Venereologica Suppl (Stockh) Suppl 89, 47–52.
Mahajan, P.M., Jadhav, V.H., Patki, A.H., Jogaikar, D.G. and Mehta, J.M., 1994. Oral zinc therapy in recurrent erythema nodosum leprosum: a clinical study. Indian Journal of Leprosy 66, 51–57.
Mathur, N.K., Bumb, R.A. and Mangal, H.N., 1983. Oral zinc in recurrent Erythema Nodosum Leprosum reaction. Lepr India 55, 547–552.
Mathur, N.K., Bumb, R.A., Mangal, H.N. and Sharma, M.L., 1984. Oral zinc as an adjunct to dapsone in lepromatous leprosy. International journal of leprosy and other mycobacterial diseases 52, 331–338.
Maverakis, E., Fung, M.A., Lynch, P.J., Draznin, M., Michael, D.J., Ruben, B. and Fazel, N., 2007. Acrodermatitis enteropathica and an overview of zinc metabolism. Journal of American Academic Dermatology 56, 116–124.
Moneib, H.A., Salem, S.A. and Darwish, M.M., 2010. Evaluation of zinc level in skin of patients with necrolytic acral erythema. British Journal of Dermatology 163, 476–480.
Najarian, D.J., Najarian, J.S., Rao, B.K. and Pappert, A.S., 2008. Hypozincemia and hyperzincuria associated with necrolytic acral erythema. International Journal of Dermatology 47, 709–711.
Najim, R.A., Sharquie, K.E. and Farjou, I.B., 1998. Zinc sulphate in the treatment of cutaneous leishmaniasis: an in vitro and animal study. Memorias do Instituto Oswaldo Cruz 93, 831–837.
Orris, L., Shalita, A.R., Sibulkin, D., London, S.J. and Gans, E.H., 1978. Oral zinc therapy of acne. Absorption and clinical effect. Archives of Dermatology 114, 1018–1020.
Perafan-Riveros, C., Franca, L.F., Alves, A.C. and Sanches Jr., J.A., 2002. Acrodermatitis enteropathica: case report and review of the literature. Pediatric Dermatology 19, 426–431.
Plum, L.M., Lothar, R. and Haase, H., 2010. The essential toxin: impact of zinc on human health. International Journal of Environmental Research on Public Health 7, 1342–1365.
Prasad, A.S., 2009. Zinc: role in immunity, oxidative stress and chronic inflammation. Current Opinion in Clinical Nutrition and Metabolic Care 12, 646–652.
Prasad, A.S., Halsted, J.A. and Nadimi, M., 1961. Syndrome of iron deficiency anemia, hepatosplenomegaly, hypogonadism, dwarfism and geophagia. American Journal of Medicine 31, 532–546.
Rebello, T., Atherton, D.J. and Holden, C., 1986. The effect of oral zinc administration on sebum free fatty acids in acne vulgaris. Acta Dermato-Venereologica 66, 305–310.
Sardana, K. and V.K. Garg, 2010. “An observational study of methionine-bound zinc with antioxidants for mild to moderate acne vulgaris.” Dermatology and Therapy 23, 411–418.
Sadighha, A., 2009. Oral zinc sulphate in recalcitrant multiple viral warts: a pilot study. Journal of the European Academy of Dermatology and Venereology 23, 715–716.
Sharquie, K.E. and Najim, R.A., 2004. Disseminated cutaneous leishmaniasis. Saudi Medical Journal 25, 951–954.
Sharquie, K.E., Najim, R.A., Al-Dori, W.S. and Al-Hayani, R.K., 2006a. Oral zinc sulfate in the treatment of Behcet’s disease: a double blind cross-over study. Journal of Dermatology 33, 541–546.
Sharquie, K.E., Najim, R.A., Al-Hayani, R.K., Al-Nuaimy, A.A. and Maroof, D.M., 2008. The therapeutic and prophylactic role of oral zinc sulfate in management of recurrent aphthous stomatitis (ras) in comparison with dapsone. Saudi Medical Journal 29, 734–738.
Sharquie, K.E., Najim, R.A. and Al-Salman, H.N., 2006b. Oral zinc sulfate in the treatment of rosacea: a double-blind, placebo-controlled study. International Journal of Dermatology 45, 857–861.
Sharquie, K.E., Najim, R.A., Farjou, I.B. and Al-Timimi, D.J., 2001. Oral zinc sulphate in the treatment of acute cutaneous leishmaniasis. Clinical and Experimental Dermatology 26, 21–26.
Trumbo, P., Yates, A.A., Schlicker, S. and Poos, M., 2001, Dietary Reference Intakes: Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Journal of the American Dietetic Association 101, 294–301.
Tuerk, M.J. and Fazel, N., 2009. Zinc deficiency. Current Opinion in Gastroenterology 25, 136–143.
United States Department of Agriculture (USDA), 2010. USDA Nutrient Database for Standard Reference. Release 23, available at: http://www.nal.usda.gov/fnic/foodcomp/search/.
Verma, K.C., Saini, A.S. and Dhamija, S.K., 1980. Oral zinc sulphate therapy in acne vulgaris: a double-blind trial. Acta Dermato-Venereologica 60, 337–340.
Weimar, V.M., Puhl, S.C., Smith, W.H. and tenBroeke, J.E., 1978. Zinc sulfate in acne vulgaris. Archive of Dermatology 114, 1776–1778.
Yaghoobi, R., Sadighha, A. and Baktash, D., 2009. Evaluation of oral zinc sulfate effect on recalcitrant multiple viral warts: a randomized placebo-controlled clinical trial. Journal of American Academic Dermatololgy 60, 706–708.
Zedek, D., Morrell, D.S., Graham, M., Goodman, D. and Groben, P., 2008. Acrodermatitis enteropathica-like eruption and failure to thrive as presenting signs of cystic fibrosis. Journal of American Academic Dermatology 58, S5-8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Rights and permissions
Copyright information
© 2012 Wageningen Academic Publishers
About this chapter
Cite this chapter
Bangash, H.K., Sethi, A. (2012). Zinc and skin health: an overview. In: Preedy, V.R. (eds) Handbook of diet, nutrition and the skin. Human Health Handbooks no. 1, vol 2. Wageningen Academic Publishers. https://doi.org/10.3920/978-90-8686-729-5_11
Download citation
DOI: https://doi.org/10.3920/978-90-8686-729-5_11
Publisher Name: Wageningen Academic Publishers
Online ISBN: 978-90-8686-729-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)